MHI Thermal Systems Launches Two New Models of Air-to-Water Heat Pumps Using Natural Refrigerant R290 for European Market

Hydrolution EZY Series TOKYO, October 30, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has added two new models to its “Hydrolution EZY” series of air-to-water (ATW) heat pumps for the European market that utilize R290 (propane). This is […]

Hitachi Energy and Blackstone Energy Transition Partners enter strategic partnership to create leading energy service provider in North America

Zurich and New York, October 30, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi Energy, a wholly owned subsidiary of Hitachi, Ltd., today announced a strategic partnership with Blackstone Energy Transition Partners (“Blackstone”) to expand and strengthen its Service business, supporting customers in maintaining the reliability and safety of power infrastructure across North America. As […]

MHI-MS to Conduct Demonstration Testing of Vehicle Transport Robots at Nakagusuku Port in Okinawa

Vehicle transport robots TOKYO, October 30, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy Industries Machinery Systems (MHI-MS), a part of Mitsubishi Heavy Industries (MHI) Group, will conduct demonstration testing of finished vehicle logistics (FVL) using vehicle transport robots to autonomously move automobiles. Following a proposal adopted for “Testbed Support Subsidy Program”(*1) conducted by […]

DENSO Hosted a Press Briefing at JAPAN MOBILITY SHOW 2025

KARIYA, JAPAN, Oct. 30, 2025 – (JCN Newswire via SeaPRwire.com) – DENSO CORPORATION hosted a press briefing at JAPAN MOBILITY SHOW 2025 held at Tokyo Big Sight on October 30.   Shinnosuke Hayashi, President & CEO, DENSO CORPORATIONFull transcript of the speech —————————— Good morning, I’m Shinnosuke Hayashi from DENSO.Thank you very much for joining […]

Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center

TOKYO, Oct 29, 2025 – (JCN Newswire via SeaPRwire.com) – Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI™ observation mode, which combines Narrow Band Imaging (NBI™ mode) and Texture and Color Enhancement Imaging (TXI™ mode) into a single view. […]

Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma

TOKYO and RAHWAY, NJ, Oct. 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai (Headquarters: Tokyo, CEO: Haruo Naito) and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) today announced results from that Phase 3 LEAP-012 trial evaluating LENVIMA® (lenvatinib), the orally available multiple receptor tyrosine […]

Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025

HIROSHIMA, Japan, October 29, 2025 – (JCN Newswire via SeaPRwire.com) – During the press conference at the Japan Mobility Show 2025(*1) today, Mazda Motor Corporation (Mazda) unveiled two vision models, the MAZDA VISION X-COUPE and the MAZDA VISION X-COMPACT (‘X’ pronounced as ‘cross’ ), both embodying the Company’s theme for this year’s exhibition: “The Joy […]

NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI

TOKYO, Japan, October 29, 2025 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) and the Cambodian Mine Action Center (CMAC, *1), the national institution responsible for landmine clearance activities in Cambodia, with assistance from JICA (*2), conducted a proof-of-concept using AI to predict landmine-contaminated areas. This initiative aims to contribute to rapid […]

Merck & Co., Inc. and Eisai Announce WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma

RAHWAY, NJ and TOKYO, October 28, 2025 – (JCN Newswire via SeaPRwire.com) – Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) and Eisai (Headquarters: Tokyo, CEO: Haruo Naito) today announced that the Phase 3 LITESPARK-011 trial evaluating the dual oral regimen of WELIREG® (belzutifan), the first-in-class […]